Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma
Authors
Keywords
-
Journal
International Journal of Nanomedicine
Volume Volume 17, Issue -, Pages 3989-4008
Publisher
Informa UK Limited
Online
2022-09-06
DOI
10.2147/ijn.s376172
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy
- (2021) Jinsheng Huang et al. BIOMATERIALS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer
- (2021) Yiran Si et al. International Journal of Nanomedicine
- Clinical outcomes and influencing factors of PD‑1/PD‑L1 in hepatocellular carcinoma (Review)
- (2021) Jiting Wang et al. Oncology Letters
- Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity
- (2021) Suah Yang et al. BIOMATERIALS
- Ultrasound-Mediated Gemcitabine Delivery Reduces the Normal-Tissue Toxicity of Chemoradiation Therapy in a Muscle-Invasive Bladder Cancer Model
- (2021) Jia-Ling Ruan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
- (2021) Shirin Hafezi et al. Cancers
- Gemcitabine-loaded microbubble system for ultrasound imaging and therapy
- (2021) Lauren J. Delaney et al. Acta Biomaterialia
- Self-delivery oxidative stress amplifier for chemotherapy sensitized immunotherapy
- (2021) Linping Zhao et al. BIOMATERIALS
- Ultrasound-triggered imaging and drug delivery using microbubble-self-aggregate complexes
- (2021) In Jae Chung et al. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
- Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment
- (2021) Md Abdus Subhan et al. Journal of Personalized Medicine
- Ultrasound Microbubbles Mediated Sonosensitizer and Antibody Co-delivery for Highly Efficient Synergistic Therapy on HER2-Positive Gastric Cancer
- (2021) Lihong Sun et al. ACS Applied Materials & Interfaces
- Tumor microenvironment-responsive Ag2S-PAsp(DOX)-cRGD nanoparticles-mediated photochemotherapy enhances the immune response to tumor therapy
- (2021) Ruxia Han et al. BIOMATERIALS
- Highlights in ultrasound-targeted microbubble destruction-mediated gene/drug delivery strategy for treatment of malignancies
- (2021) Hui Li et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A Novel Strategy Conjugating PD-L1 Polypeptide With Doxorubicin Alleviates Chemotherapeutic Resistance and Enhances Immune Response in Colon Cancer
- (2021) Maolin Wang et al. Frontiers in Oncology
- Ultrasound-Targeted Microbubble Destruction Alleviates Immunosuppression Induced by CD71+ Erythroid Progenitor Cells and Promotes PDL-1 Blockade Immunotherapy in the Lewis Lung Cancer Model
- (2021) Xi Tan et al. Frontiers in Oncology
- Nanosonosensitizers With Ultrasound-Induced Reactive Oxygen Species Generation for Cancer Sonodynamic Immunotherapy
- (2021) Danling Cheng et al. Frontiers in Bioengineering and Biotechnology
- Magnetic Targeting and Ultrasound Activation of Liposome–Microbubble Conjugate for Enhanced Delivery of Anticancer Therapies
- (2020) Pankaj Dwivedi et al. ACS Applied Materials & Interfaces
- Nanobowl-Supported Liposomes Improve Drug Loading and Delivery
- (2020) Zhong-Jian Chen et al. NANO LETTERS
- Ultrasound Molecular Imaging of Renal Cell Carcinoma: VEGFR targeted therapy monitored with VEGFR1 and FSHR targeted microbubbles
- (2020) Alexandre Ingels et al. Scientific Reports
- Anticancer DOX delivery system based on CNTs: Functionalization, targeting and novel technologies
- (2020) Alireza Yaghoubi et al. JOURNAL OF CONTROLLED RELEASE
- Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
- (2020) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
- (2020) Thomas Powles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker
- (2020) Zhengyi Wang et al. Cancer Medicine
- Ultrasound targeting of microbubble-bound anti PD-L1 mAb to enhance anti-tumor effect of cisplatin in cervical cancer xenografts treatment
- (2020) Yao Ma et al. LIFE SCIENCES
- Targeting immunogenic cell death in cancer
- (2020) Asma Ahmed et al. Molecular Oncology
- PD-L1 Targeting Immune-Microbubble Complex Enhances Therapeutic Index in Murine Colon Cancer Models
- (2020) Daehyun Kim et al. Pharmaceuticals
- Tumor perfusion enhancement by ultrasound stimulated microbubbles potentiates PD-L1 blockade of MC38 colon cancer in mice
- (2020) Ningshan Li et al. CANCER LETTERS
- Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation
- (2020) Elizabeth C. Paver et al. PATHOLOGY
- PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations
- (2019) Yongshuai Jiang et al. Human Vaccines & Immunotherapeutics
- Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Doxorubicin and Anti-PD-L1 Antibody Conjugated Gold Nanoparticles for Colorectal Cancer Photochemotherapy
- (2019) Fakhrossadat Emami et al. MOLECULAR PHARMACEUTICS
- Sonodynamic Therapeutic Effects of Sonosensitizers with Different Intracellular Distribution Delivered by Hollow Nanocapsules Exhibiting Cytosol Specific Release
- (2019) Ryoma Teranishi et al. MACROMOLECULAR BIOSCIENCE
- Advances in cancer immunotherapy 2019 – latest trends
- (2019) Stephan Kruger et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Enhancing Nab-Paclitaxel Delivery Using Microbubble-Assisted Ultrasound in a Pancreatic Cancer Model
- (2019) Diane Bressand et al. MOLECULAR PHARMACEUTICS
- Ultrasound Molecular Imaging of Atherosclerosis With Nanobodies
- (2019) Mukesh Punjabi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The suppressive effect of co-inhibiting PD-1 and CTLA-4 expression on H22 hepatomas in mice
- (2018) Leilei Liang et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives
- (2018) T. Mocan et al. Clinical & Translational Oncology
- C-Terminal Residue of Ultrashort Peptides Impacts on Molecular Self-Assembly, Hydrogelation, and Interaction with Small-Molecule Drugs
- (2018) Kiat Hwa Chan et al. Scientific Reports
- Cardiomyocyte death in doxorubicin-induced cardiotoxicity
- (2009) Yi-Wei Zhang et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started